1-Chloro-4-iodobutane

We are 1-Chloro-4-iodobutane CAS:10297-05-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Chloro-4-iodobutane
CAS.NO:10297-05-9
Synonyms:1-Chloro-4-iodobutane
Butane, 1-chloro-4-iodo-
4-Chlorobutyl Iodide
4-Iodobutyl Chloride
Molecular Formula:C4H8ClI
Molecular Weight:218.46400
 
Physical and Chemical Properties:
Density:1.785
Melting point:93ºC
Flash point:200°F
Index of Refraction:1.540
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:The substance is unstable and should be kept away from light and refrigerated
Application:Organic synthesis intermediate

1-Chloro-4-iodobutane


Related News: Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.987-65-5 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.1133057-97-2 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.Ácido 3-cloro-4-metoxibenzoico CAS:37908-96-6 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”

Related Products
Product Name
4-bromobenzo[a]anthracene View Details
6-chloropyridine-3-carbonitrile View Details
5-Bromo-1,2,3-trifluorobenzene View Details
1-CHLORO-6-IODOHEXANE manufacturer Tetrahydroxydiboron manufacturer prop-2-yn-1-ol manufacturer chloromethyl butanoate Cas:33657-49-7 manufacturer 2,3-Difluoropyridine manufacturer